SCHEMBL5259342

SCHEMBL5259342

FC(F)(F)C1CCN(c2[c]cccn2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.37
KDM4E B2RXH2 2/20 0.36
MAPT P10636 1/20 0.36
CYP3A4 P08684 4/20 0.35
MAP4K4 O95819 1/20 0.33
VNN1 O95497 2/20 0.33
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
CYP2C19 P33261 2/20 0.32
CYP2C9 P11712 1/20 0.32
CHRM3 P20309 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
SCN10A Q9Y5Y9 1/20 0.31
IDH1 O75874 1/20 0.31
NAMPT P43490 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.31
SPR P35270 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5257095 0.91 MAP4K4 (0.40) PDE10AKDM4EMAPTCYP3A4MAP4K4
SCHEMBL354103 0.77 SMPD3 (0.40) KDM4EMAPTCYP2C19CYP2C9
SCHEMBL2066303 0.77 SMPD3 (0.36) KDM4EMAPTCYP2C19CYP2C9
SCHEMBL27924126 0.77 DYRK1A (0.38) PDE10AKDM4ECYP2C19CHRM3PDE4A
SCHEMBL2579053 0.75 CNR2 (0.39) MAPTCYP2C19CYP2C9
SCHEMBL27943366 0.73 PDE10A (0.38) PDE10AKDM4ECYP2C19IRAK4
SCHEMBL17353164 0.73 PDE10A (0.38) PDE10AKDM4ECYP2C19IRAK4
SCHEMBL353955 0.73 POLB (0.41) KDM4EMAPTPIK3CACYP2C9
SCHEMBL29195337 0.73 ALDH1A1 (0.37) PIK3CA
SCHEMBL2066450 0.73 KDM4E (0.53) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747206-A1 AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE ABBOTT LABORATORIES (US) 2007-01-31 EP disclosed
WO-2005111003-A1 AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE ABBOTT LABORATORIES (US) 2005-11-24 WO disclosed
WO-2003007955-A2 BIPHENYL APURINIC/APYRIMIDINIC SITE ENDONUCLEASE INHIBITORS TO TREAT CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2003-01-30 WO disclosed